News | Radiology Business | December 14, 2023

Kathy Spencer-Pike brings more than two decades of experience within highly matrixed Fortune 50 environments as well as fast-paced growth and start-up enterprises

Nucleus RadioPharma, a fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, announced the appointment of Kathy Spencer-Pike as Chief Commercial Officer

Katherine Spencer-Pike, Photo: Business Wire


December 14, 2023 — Nucleus RadioPharma, a fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, announced the appointment of Kathy Spencer-Pike as Chief Commercial Officer. As a seasoned veteran with decades of commercial experience at McKesson, Novo Nordisk, Sanofi and Pfizer, Spencer-Pike will be responsible for accelerating the growth of the startup following its oversubscribed $56M Series A in October. Spencer-Pike follows a string of C-Suite appointments including Geoff Johnson, M.D., Ph.D. as Chief Scientific Officer, Kevin Haehl as Chief Development Officer and Mark Przekop as Chief Operating Officer.

“Kathy’s sterling track record of enhancing organizational value, paired with her expertise in creating, developing, and leading high-achieving teams in new business, client success, and business expansion is the perfect addition to round out our C-Suite,” said Charles S. Conroy, CEO of Nucleus RadioPharma. “On the heels of our successful funding round to increase the radiopharmaceutical accessibility, we are eager to lean on Kathy’s experience and insight to accelerate further growth and advance our commitment to delivering life-saving treatments to patients with cancer.”

Before Nucleus, Spencer-Pike was Chief Sales Officer at McKesson where she spurred significant company growth, built a high-performance commercial team and merged three legacy organizations into a single commercial organization achieving unprecedented double-digit growth year over year. Spencer-Pike previously was VP, Commercial Leader for Novo Nordisk, successfully leading the planning, development and execution of market and sales strategies, exceeding revenue goals. In addition to her commercial experience, Spencer-Pike is a dedicated advocate for DE&I, leading the largest US-based Women’s Employee Resource Group (ERG) at Pfizer and Novo Nordisk, both of which were the largest ERGs within the companies. This experience speaks to her commitment to growth and development and fostering inclusive cultures.

For more information: https://nucleusrad.com/


Related Content

News | Information Technology

April 25, 2024 — NewVue Inc., a leader in innovative cloud-native radiology workflow solutions, announced a strategic ...

Time April 25, 2024
arrow
News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Artificial Intelligence

April 19, 2024 — Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology ...

Time April 22, 2024
arrow
News | Mammography

April 16, 2024 — The Radiological Society of North America (RSNA) and GE HealthCare announced their collaboration to ...

Time April 16, 2024
arrow
News | Radiopharmaceuticals and Tracers

April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...

Time April 05, 2024
arrow
News | X-Ray

April 1, 2024 — MinXray, a leading manufacturer of imaging systems for medical and veterinary use, recently sent its ...

Time April 01, 2024
arrow
News | PACS

April 1, 2024 — SynthesisHealth LLC has completed the implementation of components that enable remote clinical ...

Time April 01, 2024
arrow
News | Molecular Imaging

March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...

Time March 29, 2024
arrow
News | Electronic Medical Records (EMR)

March 28, 2024 — Immediately releasing radiology reports under the 21st Century Cures Act (Cures Act) empowers patients ...

Time March 28, 2024
arrow
Subscribe Now